Listen "Jul 20 2017 Flashing Briefing"
Episode Synopsis
For July 20, 2017. Artificial Intelligence is about to play a major role in the pharmaceutical industry. On July 2nd of this year, Glaxo-Smith-Kline revealed a 43-million dollar deal in which they will use A.I. to make the process of discovering new drugs easier. The goal is to reduce the time it takes from identifying a target for disease intervention to finding a molecule that acts against it. He hopes to bring it from an average 5 and a half years today to just one year in the very near future.
More episodes of the podcast Biopharma EHS
Biopharma EH&S podcast episode #27
03/02/2020
Biopharma EHS Podcast Episode 26
03/01/2020
BioPharma EHS Podcast Episode 25
06/05/2017
Biopharma EHS Podcast Episode #24
17/01/2016
Biopharma EHS Podcast Episode #23
19/11/2014
Risk-MaPP, ADEs, and PDEs: Their importance to multi-product pharmaceutical manufacturing facilities
24/10/2014
Biopharma EHS Podcast Episode No. 20
14/07/2013